InvestorsHub Logo
Followers 144
Posts 27707
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Wednesday, 01/19/2022 11:13:39 AM

Wednesday, January 19, 2022 11:13:39 AM

Post# of 964
Analysts Offer Insights on Healthcare Companies: Gamida Cell (GMDA)

January 19 2022 - 08:36AM

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gamida Cell (GMDA – Research Report) and Acutus Medical (AFIB – Research Report) with bullish sentiments. Gamida Cell (GMDA) Needham analyst Gil Blum maintained a Buy rating on Gamida Cell today and set a price target of $12.00. The company's shares closed last Tuesday at $2.22, close to its 52-week low of $2.10. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gamida-cell-gmda-and-acutus-medical-afib?utm_source=advfn.com&utm_medium=referral
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.